Comprehensive analysis of disulfidptosis-related genes and the immune microenvironment in heart failure DOI Creative Commons

Linna Zhao,

Juanjuan Zhang, Qiuhang Song

и другие.

Frontiers in Cell and Developmental Biology, Год журнала: 2025, Номер 12

Опубликована: Янв. 17, 2025

Background Heart failure (HF) is a prevalent cardiovascular disease that currently lacks effective treatment options due to its intricate pathogenesis. A recent study has linked disulfidoptosis, novel form of cell demise, with the development range diseases. Nonetheless, effect disulfidoptosis on immune microenvironment HF not well comprehended. In this paper, bioinformatics analysis was performed investigate how disulfidptosis-related genes (DRGs) affect HF. Methods The expression four DRGs initially examined using bulk RNA-Seq and single-cell RNA sequencing data. predictive model subsequently developed. Consensus clustering used distinguish between two clusters DRGs. these characteristics further explored, such as infiltrating cells, response gene sets, HLAs genes. Results All were dysregulated in samples. based effectively differentiated patients healthy individuals, which validated experiment. These strongly associated abundance monocytes. Moreover, our identified distinct exhibited differences terms abundance, response, HLA expression. biological functions also revealed. Conclusion Our discovery underscores pivotal role shaping diversity intricacy

Язык: Английский

Ferroptosis-induced immunomodulation with biometabolic MOF@COF nanovaccine for self-boosting anti-tumor immunotherapy DOI

Hao Zhang,

Yue Cao, Wanying Li

и другие.

Chemical Engineering Journal, Год журнала: 2024, Номер 493, С. 152675 - 152675

Опубликована: Июнь 1, 2024

Язык: Английский

Процитировано

6

Engineered nano-aluminum adjuvant for cancer immunotherapy: Progress, challenges and opportunities towards preclinical/clinical application DOI Creative Commons
Chong Gao, Jianping Jiang, Jing Zhao

и другие.

Coordination Chemistry Reviews, Год журнала: 2024, Номер 519, С. 216109 - 216109

Опубликована: Авг. 1, 2024

Immunotherapy is a promising strategy to inhibit the progression of solid tumors. However, current vaccine adjuvants represented by aluminum adjuvant (Alum) fail tumor antigens initiate effective T cell immunity. Despite efforts have been made optimize physical characteristics Alum, lack specific immunostimulatory functions still results in their inability effectively induce cytotoxic immune responses. Encouragingly, an iterative layered double hydroxide (LDH) nano‑aluminum (NanoAlum) re-engineered from clinical AlOOH Alum and Mg(OH)2 antacid has shown efficacy evoking both potent humoral cellular Notably, it can also serve as microenvironmental immunomodulator reshape aberrant physicochemical attributes microenvironment. Interestingly, highly flexible crystal structure chemical composition offer variety LDH-based candidates (NanoMAlum) doping with body essential nutritional metal ions (M), which show great potential amplify immunotherapy. In this review, we summarize development progress LDH NanoAlum its variants NanoMAlum for cancer By rethinking challenges that hindered preclinical/clinical application, charted research pathway based on engineered organoids accelerate applications these NanoMAlums review.

Язык: Английский

Процитировано

6

Transferrin‐Based Bismuth Nanoparticles for Radiotherapy with Immunomodulation Against Orthotopic Glioma DOI Open Access
Xiaoyu Huang,

Wei Ge,

Shuxian Li

и другие.

Advanced Healthcare Materials, Год журнала: 2025, Номер unknown

Опубликована: Янв. 10, 2025

Abstract Modern radiotherapy frequently employs radiosensitizers for radiation dose deposition and triggers an immunomodulatory effect to enhance tumor destruction. However, developing glioma‐targeted sensitizers remains challenging due the blood–brain barrier (BBB) multicomponent instability. This study aims green‐synthesize transferrin–bismuth nanoparticles (TBNPs) as biosafe X‐ray absorption by tumors stimulate immune response glioma therapy. The proposed protein‐based strategy provides TBNPs with BBB‐crossing ability prevents off‐target toxicity. Cellular experiments following 4 Gy of irradiation reveal that increase DNA damage in cells trigger immunomodulation, thereby inducing immunogenic cell death. Furthermore, effectively inhibit growth through synergistic immunotherapy orthotopic mouse model. findings highlight promising effective immunomodulation.

Язык: Английский

Процитировано

0

Copper-doped layered double hydroxides co-deliver proteins/drugs for cascaded chemodynamic/immunotherapy via dual regulation of tumor metabolism DOI
Gaoming Li, Zhi‐Qiang Wang, Yunqi Guo

и другие.

Acta Biomaterialia, Год журнала: 2025, Номер unknown

Опубликована: Фев. 1, 2025

Язык: Английский

Процитировано

0

Exploiting metabolic vulnerabilities through synergistic ferroptosis and disulfidptosis for breast cancer therapy DOI Creative Commons
Yu Liang,

Hekui Lan,

Qiuyu Li

и другие.

Journal of Advanced Research, Год журнала: 2025, Номер unknown

Опубликована: Март 1, 2025

Ferroptosis represents a promising therapeutic approach for breast cancer treatment. However, cells can develop resistance through the SLC7A11-GSH-GPX4 axis, wherein increased SLC7A11 expression enhances cystine uptake, replenishes GSH, and reactivates GPX4. Notably, with high become vulnerable to disulfidptosis under glucose-deprived conditions. We aimed dual-mode strategy that simultaneously induces ferroptosis by targeting both lipid peroxidation glucose metabolism in cells. Fe-Cu-SS metal-organic frameworks (MOFs) loaded BAY876 (FCSP@876 MOFs) were synthesized enhance trigger The MOFs characterized using transmission electron microscopy (TEM), Fourier-transform infrared (FTIR) spectroscopy, X-ray photoelectron spectroscopy (XPS), UV-Vis spectroscopy. In vitro experiments demonstrated FCSP@876 reactive oxygen species (ROS) levels while depleting NADPH. Western blotting actin filament staining confirmed underlying mechanisms. vivo xenograft BALB/c mice assessed synergistic effects of induction. During induction, exhibited an adaptive upregulation expression. effectively counteracted this mechanism inducing restricting uptake BAY876, leading NADPH depletion subsequent disulfidptosis. Both enhanced efficacy compared single-mode treatments. This study successfully developed novel combines MOFs, offering overcoming therapy.

Язык: Английский

Процитировано

0

Targeting PFKFB4 Biomimetic Codelivery System Synergistically Enhances Ferroptosis to Suppress Small Cell Lung Cancer and Augments the Efficacy of Anti‐PD‐L1 Immunotherapy DOI Creative Commons
Xiang Liu,

Jingjun He,

Haoxuan Ying

и другие.

Advanced Science, Год журнала: 2025, Номер unknown

Опубликована: Апрель 11, 2025

Abstract Small cell lung cancer (SCLC) is an extremely aggressive and highly malignant type of that frequently develops resistance recurrence following initial treatment. Paclitaxel (PTX) a second‐line therapeutic option for SCLC patients with to first‐line However, its clinical application limited due suboptimal efficacy the risk hypersensitivity reactions. To address these challenges, novel strategy employing cationic liposome‐based biomimetic drug co‐delivery system, siPFKFB4/PRL PTX @RBCM‐cRGD, which simultaneously delivers paclitaxel PFKFB4‐targeting small interfering RNA (siRNA) cells tissues proposed. These findings demonstrate this system can induce ferroptosis in cells, thereby enhancing their sensitivity paclitaxel. Moreover, It promotes infiltration immune secretion cytokines within microenvironment, effectively activating anti‐tumor immunity. When combined anti‐PD‐L1 antibodies, it further potentiates responses. results suggest codelivery not only induces enhance but also reprograms potentiating effects immunotherapy providing promising new SCLC.

Язык: Английский

Процитировано

0

Genetically engineered membrane-based nanoengagers for immunotherapy of pancreatic cancer DOI Creative Commons
Haoqi Zhang, Yuanke Li,

Helong Kang

и другие.

Journal of Nanobiotechnology, Год журнала: 2024, Номер 22(1)

Опубликована: Март 11, 2024

Abstract Modulating macrophages presents a promising avenue in tumor immunotherapy. However, cells have evolved mechanisms to evade macrophage activation and phagocytosis. Herein, we introduced bispecific antibody-based nanoengager facilitate the recognition phagocytosis of by macrophages. Specifically, genetically engineered two single chain variable fragments (scFv) onto cell membrane: anti-CD40 scFv for engaging with anti-Claudin18.2 (CLDN18.2) interacting cells. These nanoengagers were further constructed coating scFv-anchored membrane into PLGA nanoparticle core. Our developed significantly boosted immune responses, including increased macrophages, enhanced antigen presentation, elevated cytotoxic T lymphocyte activity. combined benefits resulted enhancing antitumor efficacy against highly aggressive “cold” pancreatic cancer. Overall, this study offers versatile design immunotherapy, achieved through engineering incorporate antibody-anchored membrane.

Язык: Английский

Процитировано

4

A promising new approach to cancer therapy: Manipulate ferroptosis by hijacking endogenous iron DOI
Luwen Zhu, Yong‐Zhong Du

International Journal of Pharmaceutics, Год журнала: 2024, Номер 662, С. 124517 - 124517

Опубликована: Июль 29, 2024

Язык: Английский

Процитировано

4

A Bimetallic Nanomodulator to Reverse Immunosuppression via Sonodynamic‐Ferroptosis and Lactate Metabolism Modulation DOI

Xi Deng,

Yutong Zhu,

Zideng Dai

и другие.

Small, Год журнала: 2024, Номер 20(47)

Опубликована: Авг. 16, 2024

Triple-negative breast cancer (TNBC) responds poorly to immunotherapy due insufficient immunogenicity and highly immunosuppressive tumor microenvironment (TME). Herein, an intelligent calcium/cobalt-based nanomodulator (Ca,Co)CO

Язык: Английский

Процитировано

4

Biodegradable Persistent Luminescence Nanoparticles as Pyroptosis Inducer for High‐Efficiency Tumor Immunotherapy DOI Creative Commons
Lin Liu, Junpeng Shi, Jin‐Yuan Wang

и другие.

Advanced Science, Год журнала: 2024, Номер 11(39)

Опубликована: Авг. 19, 2024

Abstract Pyroptosis possesses potent antitumor immune activity, making pyroptosis inducer development a promising direction for tumor immunotherapy. Persistent luminescence nanoparticles (PLNPs) are highly sensitive optical probes extensively employed in diagnosis and therapy. However, based on PLNPs has not been reported yet. Herein, polyethylene glycol–poly lactic acid‐co‐glycolic acid (PEG–PLGA: PP) modified biodegradable CaS:Eu 2+ (CSE@PP) synthesized as immunotherapy the first time. The CSE@PP biowindow persistent (PersL) pH‐responsive degradation properties, allowing it to remain stable under neutral pH but degrade when exposed weak (pH < 6.5). During within tumor, constantly releases H 2 S Ca while its PersL gradually fades away. Thus, signal can self‐monitor release. Furthermore, released result mitochondrial dysfunction inactivation of reactive oxygen species scavenging enzymes, synergistic facilitating intracellular oxidative stress, which induces caspase‐1/GSDM‐D dependent subsequent responses. In word, is confirmed that release pyroptosis‐mediated Immunotherapy. This work will facilitate biomedical applications inspire pyroptosis‐induced

Язык: Английский

Процитировано

4